(Article by T Labs) “RETA's days are numbered.” “Here we go again.” “FDA just did WHAT?” “Another processor is gone.” “Don't panic... but PAY ATTENTION.” Every time I think we've reached peak insanity, this industry somehow finds another gear. 💳 Then THIS happened this week ... I'm not going to name names, but one of the largest, and arguably the most recognizable, peptide brands in this industry lost access to one of its credit-card processors. And no... They're not even one of the companies named in the Lilly lawsuits. These guys are MASSIVE. Not some website that appeared six months ago. Not some guy selling peptides on Facebook out of the trunk of the family SUV. 😂 We're talking about a major, established name that practically everybody who's been around this industry knows. If it can happen to them basically overnight, everybody in this industry should be paying attention. NOW IT'S REALLY STARTING TO HIT HOME. 🔥 And then Lilly drops THIS. Lilly filed six new federal lawsuits involving reta, including against Research Use Only peptide sellers. But believe it or not, the six lawsuits aren't even what concerns me most. ➡ Lilly says it has now: Referred 200+ individuals and companies to regulators and law enforcement Reported 14,000+ websites, advertisements, social posts and product listings Called on credit-card companies and payment processors to take action Called on shipping and logistics companies to take action Called on e-commerce platforms to take action Called on social-media companies to take action 🚨 THIS IS THE PART EVERYBODY NEEDS TO UNDERSTAND. ➡ The six lawsuits are the part everybody sees. But they're only the visible tip of something much bigger. ➡ Lilly says it has reported 14,000+ websites, advertisements, social-media posts and product listings involving reta across more than 100 countries. ➡ At the same time, Lilly says it has referred 200+ individuals and entities to the FDA, Department of Justice, state attorneys general, law enforcement and professional licensing boards.